Tate & Lyle Ventures

Tate & Lyle Ventures

A venture capital firm in London that focuses on innovation and product development in healthcare and biotechnology sectors

Tate & Lyle Ventures is a venture capital firm in London that focuses on innovation and product development in healthcare and biotechnology sectors. Founded 2006 in London, EnglandUnited Kingdom, this venture capital invests in early stage ventures and late stage ventures. Its portfolio companies include Changing Health, Evolve Biosystems, Nutriati, Evolve Biosystems, Lumora, Allylix, and Aquapharm Biodiscovery. As of February 2020, Tate & Lyle Ventures has made 14 investments. Their most recent investment was on December 18, 2018, when Changing Health raised £3M. Tate & Lyle Ventures has had two exits, the most notable of which include Allylix and Lumora.

Timeline

2006

Founded

Funded Companies

Company
Description
Industry
Website
Location
Evolve Biosystems

Evolve Biosystems is a company developing a consumer product, Evivo, that improves infants' gut health.

3 Results
Page 1 of 1
Results per page:
Powered by Golden Research Engine

People

Name
Role
LinkedIn

Heather Roxborough

Principal

David Atkinson

Managing Partner

Simon Barnes

Managing Partner

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

Allylix

Aquapharm Biodiscovery

Changing Health

Evolve Biosystems

Lumora

Nutriati

References

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.